mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
GSK-1904529A |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0004 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0004 |